Insilico Medicine has reduced the time needed to produce some drug development candidates to about one year by combining artificial intelligence with laboratory research in China, according to CEO Alex Zhavoronkov. The Hong Kong-listed company’s fastest programme reached candidate nomination in nine months, while its typical timeline is about 13 months, Zhavoronkov said. He said […] The post How AI is shortening drug discovery timelines in China appeared first on AI News .
← Back to news
ai
How AI is shortening drug discovery timelines in China
Log in to like articles and leave feedback.
Log in with Telegram →